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Introduction
In connection with necessity of extension of therapeutic
possibilities of migraine treatment the study of efficacy
of Levetiracetam for profilactic treatment was con-
ducted. There are not data in literature on undertaking
big randomized studies on this topic.
Background
With a glance for pharmacotherapeutic peculiarities of
action of traditional anticonvulsants, that limit their
application due to side-effects (valproic acid and topira-
mate are meant), there is a necessity of enlargement of
the range of drugs, that can be used for the prophylactic
treatment of migraine.
Objectives and methods
The study was conducted on the base of Headache Center
on patients that applied with migraine without aura [1]
with attacks resistant to NSAID or triptans, or frequent
attacks (4-8 per month). Patients were randomized on
gender, age, duration of the disease. 30 patients took Leve-
tiracetam (1000 mg/day) like prophylactic treatment for
6 months, 30 patients took valproic acid (1000 mg/day)
for 6 months, and 30 patients took Topiramate (200 mg/
day) for 6 months. Efficacy of the treatment was assessed
by quantity of days with headache during the month, qual-
ity of life index [2].
Results
Levetiracetam showed efficacy comparable with tradition-
ally used anticonvulsants. The efficacy of Levetiracetam
was unreliably lower than the efficacy of valproic acid, and
it was reliably higher than the efficacy of Topiramate.
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